Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Stockton, CA Metro Edition
Focus: LIFE SCI
Stockton's labor slack doesn't reach life sciences talent.
6.4%-6.8%
Stockton-Lodi MSA unemployment
vs 4.1% national, 5.1% California
25 jobs/month avg
Stockton metro job growth 2026
Down from 550/month average in 2025
$151,191 metro median
Research Scientist advertised pay
vs $131,354 national median, trending up
117 + ~40 roles cut
California life sciences layoffs
BioMarin (Novato) and Amgen, mid-2026
This Month's Takeaways
Local labor slack masks specialty-talent scarcity.
Stockton's 6.4%-6.8% unemployment rate sits well above the 4.1% national figure, but Research Scientist advertised pay rose to a metro median of $151,191 — above the $131,354 national figure — suggesting scientific roles are priced against statewide competition, not local surplus.
Manufacturing consolidation elsewhere raises the outsourcing question here.
BioMarin's planned Novato cuts and Amgen's July reductions point to established pharma narrowing in-state manufacturing footprints statewide. Stockton-area operations leaders weighing build-vs-outsource tradeoffs should treat this as a signal that CDMO/CRO capacity, not internal expansion, is absorbing displaced production volume.
Lab Technician pay is softening against a thinner wage backdrop.
Metro median advertised pay for Lab Technician roles fell to $52,000, a moderate decline mirroring the national drop to $47,402 median. Entry-level and support-tier roles appear more exposed to the metro's general employment weakness than credentialed scientific positions.
Regulatory affairs compensation is holding steady despite hiring pressure elsewhere.
Metro Regulatory Affairs Specialist pay sits at $109,176, stable and above the $104,000 national median, even as national commentary describes regulatory talent as an acute bottleneck with senior VP-level compensation reaching $580K. Flat advertised pay at the specialist tier may understate how tight the senior regulatory market has become.
Local Labor Conditions
Stockton metro unemployment held near 6.4%-6.8% through mid-2026, running more than two points above the national 4.1% rate and among the highest of any large metro, even as San Joaquin County job growth has slowed to a near-standstill average of 25 jobs per month versus 550 in 2025. Life sciences employers recruiting into this labor pool operate against a backdrop of broad slack in general hiring, but that slack does not extend to credentialed scientific, clinical, and regulatory roles, which remain priced against statewide and national scarcity rather than local conditions.
Leadership & Talent Implications
Metro-level labor surplus creates a false signal of easy hiring — general unemployment is elevated, but Stockton's life sciences workforce still competes against Bay Area and national demand for research, clinical, and regulatory talent, meaning advertised pay for these roles continues to track specialty scarcity rather than local softness. BioMarin's Novato cuts and Amgen's July reductions signal that established pharma is consolidating in-state manufacturing and administrative footprints while R&D and regulatory hiring stay resilient, a pattern that should inform where Stockton-area organizations draw the line between internal headcount and CDMO/CRO reliance. Consider reviewing whether current site-level compensation for research scientist and regulatory affairs roles reflects statewide competition rather than local labor supply, particularly where recruiting pulls from Bay Area commuting distance.
